Global
Asparaginase
Market is expected to grow at a significant CAGR in the upcoming
years as the scope, product types and its applications are increasing across
the globe. “Asparaginase” is also termed as “crisantaspase”. It is an enzyme
used in pharmaceutical and food industry. It is one of the medicines in the
world Health Organization’s List of Important Medicines, complete with
bacteriological classes such as Escherichia coli and Erwiniachrysanthemi. The
Asparaginase is mainly used in the manufacturing of the food to lower the effect
of acrylamide formation as Acrylamide is carcinogenic in nature and mostly used
in the starch containing food and food products such as snacks and biscuits.
Asparaginase
is also used in the pharmaceutical industry to treat various disorders and diseases
such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL),
non-Hodgkin's lymphoma, acute myeloid leukemia (AML). It is given by injection
into muscle, vein or under the skin. Asparaginase Market is categorized based
on product type, applications, and geography.
Asparaginase
Market is categorized based on product types such as Food Grade, Medical Grade.
This market is categorized based on application into Food Industry, Pharma,
Others. Asparaginase Industry is categorized based on geography into Asia
Pacific (China, India, ASEAN, Australia & New Zealand), Japan, Middle East
and Africa (GCC countries, S. Africa, Rest Of MEA), North America (U.S.,
Canada), Latin America (Brazil, Rest of Latin America), Western Europe
(Germany, Italy, France, England, Spain, Rest of Western Europe), and Eastern
Europe (Poland, Russia, Rest of Eastern Europe).
North
America has been at the forefront with regards to Asparaginase Market and will
continue to rule the roost in the years to come. The North American region is
expected to dominate the market in the forecast period, owing to a significant
revenue share of the region in the pharmaceutical industry. Additionally,
Western Europe is followed by North America in the global Asparaginase
industry, attributed to quickly increasing request for beverages and food
across the region. Eastern Europe and Japan also account for an important share
in the global Asparaginase industry. The APEJ is predictable to account for the
comparatively high-volume share in the global Asparaginase industry, owed to a
comparatively high development rate of the food industry and pharmaceutical
across the globe.
Some
of the key players that fuel the growth of the Asparaginase Market include Taj
Pharmaceuticals, Alize Pharma, Kyowa Hakko Kirin, GIHI Chemicals, United
Biotech, Liaoyuan Dikang, Changzhou Qianhong Bio-pharma, Jinan Welcome
Biochemical Pharmaceutical, ZHPHARMA, Guangzhou BaiyuanShanmingxing
Pharmaceutical, Porton Biopharma. The key players are focusing on inorganic
growth to sustain themselves amidst fierce competition. As such, mergers,
acquisitions, and joint ventures are the need of the hour.
Market Segment:
Geographically, this report is segmented
into several key Regions, with production, consumption, revenue (million USD),
market share and growth rate of Asparaginase in these regions, from 2013 to
2025 (forecast), covering
•
North America
•
Europe
•
China
•
Japan
•
Southeast Asia
•
India
Global Asparaginase market competition
by top manufacturers, with production, price, revenue (value) and market share
for each manufacturer; the top players including
•
Kyowa Hakko Kirin
•
Alize Pharma
•
Jinan Welcome Biochemical Pharmaceutical
•
Guangzhou Baiyuan Shanmingxing Pharmaceutical
•
United Biotech
•
GIHI Chemicals
•
Changzhou Qianhong Bio-pharma
•
Liaoyuan Dikang
•
ZHPHARMA
Comments
Post a Comment